Epidemiology of hepatitis A in Finland in 1990-2007

Journal of Medical Virology

Volumn 82, Issue 6, 2010, Pages 934-941

  Broman, Mia ^a   Jokinen, Sari ^a   Kuusi, Markku ^a   Lappalainen, Maija ^b   Roivainen, Merja ^a   Liitsola, Kirsi ^a   Davidkin, Irja ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Genotype; HAV; Molecular epidemiology; Outbreak; Phylogenetic analysis; Seroepidemiology

Indexed keywords

HEPATITIS A ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE TRANSMISSION; FINLAND; GENOTYPE; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; INCIDENCE; INFANT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGY; VACCINATION; VIRAL GENETICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DISEASE OUTBREAKS; FEMALE; FINLAND; GENOTYPE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VIRUS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

HEPATITIS A VIRUS;

EID: 77953523952     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21759     Document Type: Article

References (29)

1. Anastassopoulou CG, Kafatos G, Nardone A, Andrews N, Pebody RG, Mossong J, Davidkin I, Gelb D, DEO F, Thierfelder W, Nemecek V, Bruzzone B, Butur D, Barbara C, Sobotova Z, Jones L, Griskevicius A, Hesketh LM, Cohen D, Vranckx R, Tsakris A, Miller E, Hatzakis A. 2009. The European Sero-Epidemiology Network 2 (ESEN2): Standardization of assay results for hepatitis A virus (HAV) to enable comparisons of seroprevalence data across 15 countries. Epidemiol Infect 137:485-494.
2. Arauz-Ruiz P, Sundqvist L, Garcia Z, Taylor L, Visona K, Norder H, Magnius LO. 2001. Presumed common source outbreaks of hepatitis A in an endemic area confirmed by limited sequencing within the VP1 region. J Med Virol 65:449-456. (Pubitemid 32959068)
3. Bottiger M, Christenson B, Grillner L. 1997. Hepatitis A immunity in the Swedish population. A study of the prevalence of markers in the Swedish population. Scand J Infect Dis 29:99-102. (Pubitemid 27222957)
4. Chironna M, Grottola A, Lanave C, Villa E, Barbuti S, Quarto M. 2003. Genetic analysis of HAV strains recovered from patients with acute hepatitis from Southern Italy. J Med Virol 70:343-349. (Pubitemid 36638045)
5. Costa-Mattioli M, Ferre V, Monpoeho S, Garcia L, Colina R, Billaudel S, Vega I, Perez-Bercoff R, Cristina J. 2001. Genetic variability of hepatitis A virus in South America reveals heterogeneity and co-circulation during epidemic outbreaks. J Gen Virol 82:2647-2652. (Pubitemid 32998642)
6. Costa-Mattioli M, Cristina J, Romero H, Perez-Bercof R, Casane D, Colina R, Garcia L, Vega I, Glikman G, Romanowsky V, Castello A, Nicand E, Gassin M, Billaudel S, Ferre V. 2002. Molecular evolution of hepatitis A virus: A new classification based on the complete VP1 protein. J Virol 76:9516-9525.
7. Davidkin I, Zheleznova N, Jokinen S, Gorchakova O, Broman M, Mukomolov S. 2007. Molecular epidemiology of hepatitis A in St. Petersburg, Russia, 1997-2003. J Med Virol 79:657-662. (Pubitemid 46709358)
8. Gabrieli R, Sanchez G, Macaluso A, Cenko F, Bino S, Palombi L, Buonomo E, Pinto RM, Bosch A, Divizia M. 2004. Hepatitis in Albanian children: Molecular analysis of hepatitis A virus isolates. J Med Virol 72:533-537. (Pubitemid 38296063)
9. Jacobsen KH, Koopman JS. 2004. Declining hepatitis A seroprevalence: A global review and analysis. Epidemiol Infect 132:1005-1022.
10. Koff RS. 1992. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine 10:S15-S17.
11. Kuusi MNP, Nuortti P, Rostila T, Jokinen C. 2003. Hepatitis A infections in intravenous drug users, Finland, 2002. Eurosurveillance Weekly 7.
12. Leino T, Leinikki P, Hyypia T, Ristola M, Suni J, Sutinen J, Holopainen A, Haikala O, Valle M, Rostila T. 1997. Hepatitis A outbreak amongst intravenous amphetamine abusers in Finland. Scand J Infect Dis 29:213-216. (Pubitemid 27358940)
13. Linneberg A, Ostergaard C, Tvede M, Andersen LP, Nielsen NH, Madsen F, Frolund L, Dirksen A, Jorgensen T. 2003. IgG antibodies against microorganisms and atopic disease in Danish adults: The Copenhagen Allergy Study. J Allergy Clin Immunol 111:847-853. (Pubitemid 36470259)
14. Lu L, Ching KZ, de Paula VS, Nakano T, Siegl G, Weitz M, Robertson BH. 2004. Characterization of the complete genomic sequence of genotype II hepatitis A virus (CF53/Berne isolate). J Gen Virol 85:2943-2952. (Pubitemid 39360038)
15. Mukomolov SL, Shliakhtenko LI, Valle M, Plotnikova VA, Davidkin I, Levakova IA, Samokhina EV, Andreeva IA, Dmitrieva TG. 2001. Characteristics of the manifest and latent components of the hepatitis A epidemic process in cities of Russia. Zh Mikrobiol Epidemiol Immunobiol 3:35-39.
16. Nainan OV, Xia G, Vaughan G, Margolis HS. 2006. Diagnosis of hepatitis A virus infection: A molecular approach. Clin Microbiol Rev 19:63-79. (Pubitemid 43157647)
17. Normann A, Badur S, Onel D, Kilic A, Sidal M, Larouze B, Massari V, Muller J, Flehmig B. 2008. Acute hepatitis A virus infection in Turkey. J Med Virol 80:785-790. (Pubitemid 351500024)
18. Payne L, Coulombier D. 2009. Hepatitis A in the European Union: Responding to challenges related to new epidemiological patterns. Euro Surveill 14:2-3.
19. Pebody RG, Leino T, Ruutu P, Kinnunen L, Davidkin I, Nohynek H, Leinikki P. 1998. Foodborne outbreaks of hepatitis A in a low endemic country: An emerging problem? Epidemiol Infect 120: 55-59.
20. Pohjanpelto P, Lahdensivu R. 1984. Rapid decline of hepatitis A in Finland. Scand J Infect Dis 16:229-233.
21. Robertson BH, Jansen RW, Khanna B, Totsuka A, Nainan OV, Siegl G, Widell A, Margolis HS, Isomura S, Ito K, Ishizu T, Moritsugo Y, Lemon SM. 1992. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol 73: 1365-1377.
22. Shliakhtenko L, Plotnikova V, Levakova I, Rubis L, Solovieva E, Mukomolov S. 2008. Modern epidemiology of hepatitis A in the north-western region of the Russian Federation. J Viral Hepat 15:38-42.
23. Siebke JC, Degre M, Ritland S, Enger SC. 1982. Prevalence of hepatitis A antibodies in a normal population and some selected groups of patients in Norway. Am J Epidemiol 115:185-191. (Pubitemid 12182297)
24. Stene-Johansen K, Skaug K, Blystad H, Grinde B. 1998. A unique hepatitis A virus strain caused an epidemic in Norway associated with intravenous drug abuse. The Hepatitis A Study Group. Scand J Infect Dis 30:35-38. (Pubitemid 28312733)
25. Stene-Johansen K, Jonassen TO, Skaug K. 2005. Characterization and genetic variability of hepatitis A virus genotype IIIA. J Gen Virol 86:2739-2745.
26. Stene-Johansen K, Tjon G, Schreier E, Bremer V, Bruisten S, Ngui SL, King M, Pinto RM, Aragones L, Mazick A, Corbet S, Sundqvist L, Blystad H, Norder H, Skaug K. 2007. Molecular epidemiological studies show that hepatitis A virus is endemic among active homosexual men in Europe. J Med Virol 79:356-365.
27. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596-1599. (Pubitemid 47236692)
28. Ukkonen P, Pettersson R, Halonen P. 1979. Hepatitis A antibodies in Finland. Scand J Infect Dis 11:311-312.
29. von Hertzen LC, Laatikainen T, Makela MJ, Jousilahti P, Kosunen TU, Petays T, Pussinen PJ, Haahtela T, Vartiainen E. 2006. Infectious burden as a determinant of atopy - A comparison between adults in Finnish and Russian Karelia. Int Arch Allergy Immunol 140: 89-95.